reports
Trelleborg AB: 1 director
A director at Trelleborg AB bought 1,600 shares at 36.084USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Bank Ozk: 1 director
A director at Bank Ozk sold 5,875 shares at 47.950USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Eurohold Bulgaria AD: 1 director
A director at Eurohold Bulgaria AD bought 775,000 shares at 0.930BGN and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
UCB SA: 2 directors
Two Directors at UCB SA sold/bought 1,385 shares at 128.760USD. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
C I Capital Holding For Financial Investments: 1 director
A director at C I Capital Holding For Financial Investments bought 342,000 shares at 0.000EGP and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Gamuda Berhad: 1 director
A director at Gamuda Berhad sold 60,000 shares at 5.450MYR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Egyptian Modern Education Systems: 1 director
A director at Egyptian Modern Education Systems sold 2,609,759 shares at 0.000EGP and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
AFC Gamma, Inc. Announces Financial Results for First Quarter 2024
AFC Gamma, Inc. Announces Financial Results for First Quarter 2024 First quarter 2024 GAAP net loss of $(0.1) million or $(0.01) per basic weighted average common share and Distributable Earnings(1) of $10.0 million or $0.49 per basic weighted average common share Paid dividend of $0.48 per common share for first quarter 2024 WEST PALM BEACH, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma” or the “Company”) today announced its results for the first quarter ended March 31, 2024. AFC Gamma reported generally accepted accounting principles (“GAAP”) net lo...
AGS Enters Into Definitive Agreement To Be Acquired By Brightstar Capi...
AGS Enters Into Definitive Agreement To Be Acquired By Brightstar Capital Partners for Approximately $1.1 Billion LAS VEGAS and NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- PlayAGS, Incorporated (NYSE: AGS) (“AGS” or the “Company”), a global gaming supplier of high-performing slot, table, and interactive products, today announced that it has signed a definitive agreement to be acquired by affiliates of Brightstar Capital Partners (“Brightstar”), a middle market private equity firm focused on investing in industrial, manufacturing, and services businesses. The Company’s Board of Dire...
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt...
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimulated endothelial cell proliferation in the corneaSurrozen’s antibody based Wnt mimetic also increased detectable tear volume production in dry eye disease models SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- (“Surrozen” or t...
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directo...
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care Following Nuvo’s NASDAQ Listing, Addition of Machado Brings Strong Health and Impact Experience to Remote Pregnancy Monitoring Pioneer TEL AVIV, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: NUVO) (“Nuvo”), a pioneer in remote pregnancy monitoring, today announced the expansion of its board of directors with the addition of Adriana Machado, who will help guide Nuvo’s mission of addressing health disparities and social determinants of care throug...
Dorel Industries Will Hold a Conference Call to Discuss Its First Quar...
Dorel Industries Will Hold a Conference Call to Discuss Its First Quarter Results MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Dorel Industries, Inc. (TSX: DII.B, DII.A) CONFERENCE CALL:OPEN TO:Analysts, investors and all interested partiesDATE:Friday, May 10, 2024TIME:1:00 PM Eastern TimeCALL:1-800-319-4610 THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKETS OPEN THE SAME DAY THROUGH GLOBENEWSWIRE. Please dial in 15 minutes before the conference begins. If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-319-6413 and entering the passcod...
Les Industries Dorel tiendra une téléconférence pour discuter des résu...
Les Industries Dorel tiendra une téléconférence pour discuter des résultats de son premier trimestre MONTRÉAL, 09 mai 2024 (GLOBE NEWSWIRE) -- Les Industries Dorel Inc. (TSX : DII.B, DII.A) TÉLÉCONFÉRENCE :OUVERTE AUX :Analystes, investisseurs et autres personnes intéresséesDATE :Le vendredi 10 mai 2024HEURE :13 h 00, heure de l’EstTÉL. :1-800-319-4610 LE COMMUNIQUÉ DE PRESSE SERA DIFFUSÉ PAR GLOBENEWSWIRE AVANT L’OUVERTURE DES MARCHÉS LE JOUR MÊME DE LA TÉLÉCONFÉRENCE. Veuillez téléphoner 15 minutes avant l’heure prévue pour la conférence. Si vous êtes dans l’impossibilité d’y partic...
Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Heal...
Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the sale of an SRT-100 system to Chavat Da’at, the Veterinary Specialist Referral Center Knowledge Farm a...
Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegter...
Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024 COPENHAGEN, Denmark, May 09, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that new TransCon PTH (palopegteriparatide) data supporting clinical and quality-of-life benefits in adult patients with chronic hypoparathyroidism will be presented at the European Congress of Endocrinology being held May 11-14, 2024, in Stockholm. Topics include an oral presentation of new 2-year results from a post-hoc analy...
Sofwave Medical Reports First Quarter 2024 Financial Results and Busin...
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights First quarter revenue of $13.2M, +27% year-over-year growth; IFRS gross margin of 75.2%First quarter pulse recurring revenue of $4.7M, +118% year-over-year growth IFRS and non-IFRS operating loss narrowed to -$1.0M and -$0.4M, respectively; company approaching breakeven SAN CLEMENTE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial re...
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Aut...
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819 Translational Data from FT819 Phase 1 B Cell Malignancies Study Support Key Therapeutic Mechanisms of Activity for B Cell-mediated Autoimmune Diseases Initial Clinical Observations of FT522 CAR NK Cell Program in Phase 1 B Cell Lymphoma Study Show Rapid, Deep, and Sustained B Cell Depletion and Enhanced Persistence in the Periphe...
Adeia Renews Media IP License Agreement with Panasonic Entertainment &...
Adeia Renews Media IP License Agreement with Panasonic Entertainment & Communication Co., Ltd. SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the company whose patented innovations shape the way the world explores and experiences entertainment, today announced that Panasonic Entertainment & Communication Co., Ltd. (“Panasonic”), a global provider of services and products, has agreed to a multi-year renewal of its license for Adeia's media intellectual property (IP) portfolio. As a leading manufacturer of smart and connected TVs and a wide range of consume...
Femasys Announces Financial Results for Quarter Ended March 31, 2024 a...
Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update -- Recruitment of the commercial team for our infertility portfolio and the pivotal trial of FemBloc® for permanent non-surgical birth control continues -- ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces financial results for the quarter ended March 31, 2024 and pro...
Antelope Enterprise Announces Second Half and Fiscal Year End 2023 Ea...
Antelope Enterprise Announces Second Half and Fiscal Year End 2023 Earnings Conference Call The rescheduled Earnings Conference Call is to be Held on Friday, May 10, 2024 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing / Hong Kong) NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, today announced that it will conduct a conference call at 8:00 am East...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.